Page 9 of 10
ACS Medicinal Chemistry Letters
1
2
3
4
5
11 Kuduk, S.D.; Beshore, D.C. SAR Studies on Carboxylic Acid Series M1 Selective Positive Allosteric
6
Modulators (PAMs) Curr. Top. Med. Chem. 2014, 14(15) 1738ꢀ1754.
7
8
9
12 Kuduk, S.D.; Chang, R.K.; Di Marco, C.N.; Ray, W.J.; Ma, L.; Wittmann, M.; Seager, M.; Koeplinger,
K.A.; Thompson, C.D.; Hartman, G.D.; Bilodeau, M.T. Identification of Quinolizidinone Carboxylic
Acids as CNS Penetrant, Selective M1 Allosteric Muscarinic Receptor Modulators. ACS Med. Chem. Lett.
2010, 1, 263ꢀ267.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
13 Kuduk, S.D.; Chang, R.K.; Di Marco, C.N.; Ray, W.J.; Ma, L.; Wittmann, M.; Seager, M.; Koeplinger,
K.A.; Thompson, C.D.; Hartman, G.D.; Bilodeau, M.T. Quinolizidinone Carboxylic Acid Selective M1
Allosteric Modulators: SAR in the Piperidine Series. Bioorg. Med. Chem. Lett. 2011, 21, 1710ꢀ1713.
14 Kuduk, S.D.; Chang, R.K.; Di Marco, C.N.; Pitts, D.R.; Greshock, T.J.; Ma, L.; Wittmann, M.; Seager,
M.; Koeplinger, K.A.; Thompson, C.D.; Hartman, G.D.; Bilodeau, M.T.; Ray, W.J. Discovery of a
Selective Allosteric M1 Receptor Modulator with Suitable Development Properties Based on a
Quinolizidinone Carboxylic Acid Scaffold. J. Med. Chem. 2011, 13, 4773ꢀ4780.
15 Uslaner, J.M.; Eddins, D.; Puri, V.; Cannon, C.E.; Sutcliffe, J.; Chew, C.S.; Pearson, M.; Vivian, J.A.;
Chang, R.K.; Ray, W.J.; Kuduk, S.D.; Wittmann, M. The muscarinic M1 receptor positive allosteric
modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque.
Psychpharmacology 2013, 1, 21ꢀ30.
16 Kuduk, S.D.; Chang, R.K.; Greshock, T.J.; Ray, W.J.; Ma, L.; Wittmann, M.; Seager, M.A.; Koeplinger,
K.A.; Thompson, C.D.; Hartman, G.D.; Bilodeau, M.T. Identification of Amides as Carboxylic Acid
Surrogates for QuinolizidinoneꢀBased M1 Positive Allosteric Modulators. ACS Med. Chem. Lett. 2012,
3(12), 1070ꢀ1074.
17 Davoren, J.E.; Lee, C.ꢀW.; Garnsey, M.; Brodney, M.A.; Cordes, J.; Dlugolenski, K.; Edgerton, J.R.;
Harris, A.R.; Helal, C.J.; Jenkinson, S.; Kauffman, G.W.; Kenakin, T.P.; Lazzaro, J.T.; Lotarski, S.M.;
Mao, Y.; Nason, D.M.; Northcott, C.; Nottebaum, L.; O'Neil, S.V.; Pettersen, B.; Popiolek, M.; Reinhart,
V.; SalomonꢀFerrer, R.; Steyn, S.J.; Webb, D.; Zhang, L.; Grimwood, S. Discovery of the Potent and
Selective M1 PAMꢀAgonist Nꢀ[(3R,4S)ꢀ3ꢀHydroxytetrahydroꢀ2Hꢀpyranꢀ4ꢀyl]ꢀ5ꢀmethylꢀ4ꢀ[4ꢀ(1,3ꢀthiazolꢀ4ꢀ
yl)benzyl]pyridineꢀ2ꢀcarboxamide (PFꢀ06767832): Evaluation of Efficacy and Cholinergic Side Effects. J.
Med. Chem. 2016, 59(13), 6313ꢀ6328.
18 Ghose, A.K.; Herbertz, T.; Hudkins, R.L.; Dorsey, B.D.; Mallamo, J.P. KnowledgeꢀBased, Central
Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery. ACS Chem.
Neurosci. 2012, 3(1), 50ꢀ68.
19 Beshore, Douglas, C.; Kuduk, Scott, D.; DiPardo, Robert M. Pyrazoloquinolinone derivatives as M1
receptor positive allosteric modulators and their preparation and use for the treatment of M1 receptorꢀ
mediated diseases. WO 2011049731, October 1, 2010.
20
Ryckmans, T.; Edwards, M.P.; Horne, V.A.; Correia, A.M.; Owen, D.R.; Thompson, L.R.; Tran, I.; Tutt,
M.F.; Young, T. Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis
protocols: A Lipophilic Efficiency (LipE) analysis. Bioorg. Med. Chem. Lett. 2009, 19(15), 4406–4409.
21 Yang, Z.Q.; Shu, Y.; Ma, L.; Wittmann, M.; Ray, W.J.; Seager, M.A.; Koeplinger, K.A.; Thompson,
C.D.; Hartman, G.D.; Bilodeau, .T.; Kuduk, S.D. Discovery of NaphthylꢀFused 5-Membered Lactams as a
New Class of M1 Positive Allosteric Modulators. ACS Med. Chem. Lett. 2014, 5, 604−608.
22 Rowland, M.; Benet, L.Z.; Graham, G.C. Clearance concepts in pharmacokinetics. J. Pharmacokinet
Biopharm 1973, 1, 123–136.
23 Zhang, R.; Kavana, M. Quantitative Analysis of Receptor Allosterism and its Implication for Drug
Discovery. Expert Opin Drug Discov. 2015, 10(7),763ꢀ80.
ACS Paragon Plus Environment